Global Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases Market to Reach $14.7 Billion by 2030
The global market for Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases estimated at US$7.5 Billion in the year 2022, is projected to reach a revised size of US$14.7 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2022-2030.The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 8.3% CAGR
The Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.Select Competitors (Total 46 Featured) -
- AbaStar MDx
- Abbott Laboratories
- Abiant
- Acumen Pharmaceuticals
- Alseres Pharmaceuticals
- Athena Diagnostics
- Athena Diagnostics
- Banyan Biomarkers
- Bio-Rad Laboratories
- Diagenic ASA
- Immunarray Pvt. Ltd.
- Myriad RBM
- Proteome Sciences
- ProteoSys AG
- Psynova Neurotech
- Qiagen
- Quanterix Corporation
- Thermo Fisher Scientific
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbaStar MDx
- Abbott Laboratories
- Abiant
- Acumen Pharmaceuticals
- Alseres Pharmaceuticals
- Athena Diagnostics
- Athena Diagnostics
- Banyan Biomarkers
- Bio-Rad Laboratories
- Diagenic ASA
- Immunarray Pvt. Ltd.
- Myriad RBM
- Proteome Sciences
- ProteoSys AG
- Psynova Neurotech
- Qiagen
- Quanterix Corporation
- Thermo Fisher Scientific
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 7.5 Billion |
Forecasted Market Value ( USD | $ 14.7 Billion |
Compound Annual Growth Rate | 8.8% |
Regions Covered | Global |